Bernstein Maintains Outperform on Strategy, Lowers Price Target to $350

Benzinga Newsdesk www.benzinga.com Negative 89.5%

Neg 89.5% Neu 0% Pos 0%

Bernstein analyst Gautam Chhugani maintains Strategy (NASDAQ:MSTR) with a Outperform and lowers the price target from $450 to $350.